Comprehensive Stock Comparison
Compare Sabra Health Care REIT, Inc. (SBRA) vs Strawberry Fields REIT LLC (STRW) Stock
Analyze side-by-side fundamentals, valuation, growth, and profitability to decide which stock is the better buy.
Selected Stocks
Add up to 10 tickers. Use presets or search to get started.
Quick Verdict
| Category | Winner | Why |
|---|---|---|
| Growth | STRW | 17.3% revenue growth vs SBRA's 10.2% |
| Value | STRW | Lower P/E (16.4x vs 29.3x) |
| Quality / Margins | SBRA | 20.0% net margin vs STRW's 4.8% |
| Stability / Safety | SBRA | Beta 0.05 vs STRW's 0.53, lower leverage |
| Dividends | SBRA | 5.8% yield, vs STRW's 4.4% |
| Momentum (1Y) | SBRA | +30.9% vs STRW's +14.3% |
| Efficiency (ROA) | SBRA | 2.8% ROA vs STRW's 0.8% |
Who Each Stock Is For
Income & stability
Growth exposure
Long-term compounding (10Y)
Sleep-well-at-night portfolio
Defensive / Recession hedge
Business Model
What each company does and how it makes money
Sabra Health Care REIT is a real estate investment trust that owns and leases healthcare properties—primarily skilled nursing facilities and senior housing communities—to operators across the U.S. and Canada. It generates revenue almost entirely from rental income collected under long-term triple-net leases, where tenants cover most property expenses. Its competitive advantage lies in its specialized healthcare real estate portfolio and long-term relationships with established operators in a fragmented industry.
Strawberry Fields REIT is a real estate investment trust that owns and leases skilled nursing facilities and other post-acute healthcare properties. It generates revenue primarily through long-term triple-net leases—where tenants cover property expenses—with healthcare operators, creating stable rental income streams. The company's moat lies in its specialized healthcare real estate portfolio and triple-net lease structure that transfers operational risks to tenants while providing predictable cash flows.
Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
Segment breakdown not available.
Financial Metrics Comparison
Side-by-side fundamentals across 2 stocks. BestLagging
Financial Scorecard
STRW leads in 3 of 6 categories (Financial Metrics, Valuation Metrics). SBRA leads in 2 (Total Returns, Risk & Volatility). 1 tied.
Financial Metrics (TTM)
SBRA is the larger business by revenue, generating $775M annually — 5.3x STRW's $145M. SBRA is the more profitable business, keeping 20.0% of every revenue dollar as net income compared to STRW's 4.8%. On growth, STRW holds the edge at +34.8% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | SBRASabra Health Care… | STRWStrawberry Fields… |
|---|---|---|
| RevenueTrailing 12 months | $775M | $145M |
| EBITDAEarnings before interest/tax | $412M | $123M |
| Net IncomeAfter-tax profit | $155M | $7M |
| Free Cash FlowCash after capex | $261M | $88M |
| Gross MarginGross profit ÷ Revenue | +48.0% | +81.4% |
| Operating MarginEBIT ÷ Revenue | +25.7% | +54.3% |
| Net MarginNet income ÷ Revenue | +20.0% | +4.8% |
| FCF MarginFCF ÷ Revenue | +33.7% | +60.7% |
| Rev. Growth (YoY)Latest quarter vs prior year | +16.2% | +34.8% |
| EPS Growth (YoY)Latest quarter vs prior year | -100.0% | +6.7% |
Valuation Metrics
On an enterprise value basis, STRW's 8.3x EV/EBITDA is more attractive than SBRA's 18.7x.
| Metric | SBRASabra Health Care… | STRWStrawberry Fields… |
|---|---|---|
| Market CapShares × price | $5.2B | $168M |
| Enterprise ValueMkt cap + debt − cash | $6.4B | $791M |
| Trailing P/EPrice ÷ TTM EPS | — | 22.46x |
| Forward P/EPrice ÷ next-FY EPS est. | 29.34x | 16.41x |
| PEG RatioP/E ÷ EPS growth rate | — | — |
| EV / EBITDAEnterprise value multiple | 18.68x | 8.29x |
| Price / SalesMarket cap ÷ Revenue | 6.68x | 1.43x |
| Price / BookPrice ÷ Book value/share | 1.78x | 1.09x |
| Price / FCFMarket cap ÷ FCF | 14.84x | 4.75x |
Profitability & Efficiency
STRW delivers a 11.2% return on equity — every $100 of shareholder capital generates $11 in annual profit, vs $5 for SBRA. SBRA carries lower financial leverage with a 0.45x debt-to-equity ratio, signaling a more conservative balance sheet compared to STRW's 8.04x. On the Piotroski fundamental quality scale (0–9), STRW scores 7/9 vs SBRA's 6/9, reflecting strong financial health.
| Metric | SBRASabra Health Care… | STRWStrawberry Fields… |
|---|---|---|
| ROE (TTM)Return on equity | +5.5% | +11.2% |
| ROA (TTM)Return on assets | +2.8% | +0.8% |
| ROICReturn on invested capital | — | +7.2% |
| ROCEReturn on capital employed | — | +9.0% |
| Piotroski ScoreFundamental quality 0–9 | 6 | 7 |
| Debt / EquityFinancial leverage | 0.45x | 8.04x |
| Net DebtTotal debt minus cash | $1.2B | $623M |
| Cash & Equiv.Liquid assets | $72M | $48M |
| Total DebtShort + long-term debt | $1.3B | $672M |
| Interest CoverageEBIT ÷ Interest expense | — | 1.82x |
Total Returns (with DRIP)
A $10,000 investment in SBRA five years ago would be worth $15,120 today (with dividends reinvested), compared to $14,470 for STRW. Over the past 12 months, SBRA leads with a +30.9% total return vs STRW's +14.3%. The 3-year compound annual growth rate (CAGR) favors SBRA at 26.6% vs STRW's 21.6% — a key indicator of consistent wealth creation.
| Metric | SBRASabra Health Care… | STRWStrawberry Fields… |
|---|---|---|
| YTD ReturnYear-to-date | +8.9% | -1.4% |
| 1-Year ReturnPast 12 months | +30.9% | +14.3% |
| 3-Year ReturnCumulative with dividends | +102.8% | +79.8% |
| 5-Year ReturnCumulative with dividends | +51.2% | +44.7% |
| 10-Year ReturnCumulative with dividends | +76.5% | +44.7% |
| CAGR (3Y)Annualised 3-year return | +26.6% | +21.6% |
Risk & Volatility
SBRA is the less volatile stock with a 0.05 beta — it tends to amplify market swings less than STRW's 0.53 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. SBRA currently trades 97.5% from its 52-week high vs STRW's 91.4% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | SBRASabra Health Care… | STRWStrawberry Fields… |
|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 0.05x | 0.53x |
| 52-Week HighHighest price in past year | $21.07 | $14.00 |
| 52-Week LowLowest price in past year | $15.75 | $8.70 |
| % of 52W HighCurrent price vs 52-week peak | +97.5% | +91.4% |
| RSI (14)Momentum oscillator 0–100 | 69.8 | 48.8 |
| Avg Volume (50D)Average daily shares traded | 2.2M | 22K |
Analyst Outlook
Wall Street rates SBRA as "Hold" and STRW as "Buy". Consensus price targets imply 19.8% upside for STRW (target: $15) vs 3.8% for SBRA (target: $21). For income investors, SBRA offers the higher dividend yield at 5.76% vs STRW's 4.42%.
| Metric | SBRASabra Health Care… | STRWStrawberry Fields… |
|---|---|---|
| Analyst RatingConsensus buy/hold/sell | Hold | Buy |
| Price TargetConsensus 12-month target | $21.33 | $15.33 |
| # AnalystsCovering analysts | 29 | 2 |
| Dividend YieldAnnual dividend ÷ price | +5.8% | +4.4% |
| Dividend StreakConsecutive years of raises | 0 | 2 |
| Dividend / ShareAnnual DPS | $1.18 | $0.57 |
| Buyback YieldShare repurchases ÷ mkt cap | 0.0% | +1.5% |
Historical Charts
Charts are rendered on first load. Hover for details.
Chart 1Total Return — 5 Years (Rebased to 100)
| Stock | Oct 22 | Feb 26 | Change |
|---|---|---|---|
| Sabra Health Care R… (SBRA) | 100 | 139.6 | +39.6% |
| Strawberry Fields R… (STRW) | 101.73 | 132.5 | +30.3% |
Sabra Health Care R… (SBRA) returned +51% over 5 years vs Strawberry Fields R… (STRW)'s +45%. A $10,000 investment in SBRA 5 years ago would be worth $15,120 today (including dividends reinvested).
Chart 2Revenue Growth — 10 Years
| Stock | 2016 | 2025 | Change |
|---|---|---|---|
| Sabra Health Care R… (SBRA) | $261M | $775M | +197.3% |
| Strawberry Fields R… (STRW) | $84M | $117M | +39.2% |
Sabra Health Care REIT, Inc.'s revenue grew from $261M (2016) to $775M (2025) — a 12.9% CAGR.
Chart 3Net Margin Trend — 10 Years
| Stock | 2016 | 2025 | Change |
|---|---|---|---|
| Sabra Health Care R… (SBRA) | 27.0% | 20.0% | -25.7% |
| Strawberry Fields R… (STRW) | 14.1% | 3.5% | -75.3% |
Sabra Health Care REIT, Inc.'s net margin went from 27% (2016) to 20% (2025).
Chart 4P/E Ratio History — 7 Years
| Stock | 2017 | 2024 | Change |
|---|---|---|---|
| Sabra Health Care R… (SBRA) | 13.4 | 32.1 | +139.6% |
| Strawberry Fields R… (STRW) | 26.6 | 18.5 | -30.5% |
Sabra Health Care REIT, Inc. has traded in a 11x–242x P/E range over 6 years; current trailing P/E is ~32x. Strawberry Fields REIT LLC has traded in a 19x–27x P/E range over 3 years; current trailing P/E is ~22x.
Chart 5EPS Growth — 10 Years
| Stock | 2016 | 2025 | Change |
|---|---|---|---|
| Sabra Health Care R… (SBRA) | 0.92 | 0 | -100.0% |
| Strawberry Fields R… (STRW) | -2.06 | 0.57 | +127.7% |
Sabra Health Care REIT, Inc.'s EPS grew from $0.92 (2016) to $0.00 (2025) — a -100% CAGR.
Chart 6Free Cash Flow — 5 Years
Sabra Health Care REIT, Inc. generated $349M FCF in 2025 (+8% vs 2021). Strawberry Fields REIT LLC generated $35M FCF in 2024 (-21% vs 2021).
SBRA vs STRW: Frequently Asked Questions
9 questions · data-driven answers · updated daily
01Is SBRA or STRW a better buy right now?
Strawberry Fields REIT LLC (STRW) offers the better valuation at 22.5x trailing P/E (16.4x forward), making it the more compelling value choice. Analysts rate Strawberry Fields REIT LLC (STRW) a "Buy" — based on 2 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — SBRA or STRW?
On forward P/E, Strawberry Fields REIT LLC is actually cheaper at 16.4x.
03Which is the better long-term investment — SBRA or STRW?
Over the past 5 years, Sabra Health Care REIT, Inc. (SBRA) delivered a total return of +51.2%, compared to +44.7% for Strawberry Fields REIT LLC (STRW). A $10,000 investment in SBRA five years ago would be worth approximately $15K today (assuming dividends reinvested). Over 10 years, the gap is even starker: SBRA returned +76.5% versus STRW's +44.7%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — SBRA or STRW?
By beta (market sensitivity over 5 years), Sabra Health Care REIT, Inc. (SBRA) is the lower-risk stock at 0.05β versus Strawberry Fields REIT LLC's 0.53β — meaning STRW is approximately 1029% more volatile than SBRA relative to the S&P 500. On balance sheet safety, Sabra Health Care REIT, Inc. (SBRA) carries a lower debt/equity ratio of 45% versus 8% for Strawberry Fields REIT LLC — giving it more financial flexibility in a downturn.
05Which has better profit margins — SBRA or STRW?
Sabra Health Care REIT, Inc. (SBRA) is the more profitable company, earning 20.0% net margin versus 3.5% for Strawberry Fields REIT LLC — meaning it keeps 20.0% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: STRW leads at 52.4% versus 25.7% for SBRA. At the gross margin level — before operating expenses — STRW leads at 87.0%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
06Is SBRA or STRW more undervalued right now?
On forward earnings alone, Strawberry Fields REIT LLC (STRW) trades at 16.4x forward P/E versus 29.3x for Sabra Health Care REIT, Inc. — 12.9x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for STRW: 19.8% to $15.33.
07Which pays a better dividend — SBRA or STRW?
All stocks in this comparison pay dividends. Sabra Health Care REIT, Inc. (SBRA) offers the highest yield at 5.8%, versus 4.4% for Strawberry Fields REIT LLC (STRW).
08Is SBRA or STRW better for a retirement portfolio?
For long-horizon retirement investors, Sabra Health Care REIT, Inc. (SBRA) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0.05), 5.8% yield). Both have compounded well over 10 years (SBRA: +76.5%, STRW: +44.7%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
09What are the main differences between SBRA and STRW?
Both stocks operate in the Real Estate sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that beat both.